Ryman Healthcare ( (RHCGF) ) has released its Q2 earnings. Here is a breakdown of the information Ryman Healthcare presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ryman Healthcare is a New Zealand-based company that develops, owns, and operates integrated retirement villages, rest homes, and hospitals for older people in New Zealand and Australia. In its latest earnings report for the six months ended September 2025, Ryman Healthcare reported total revenue of NZD 413.78 million, an increase from NZD 366.26 million in the same period last year. However, the company faced a net loss after tax of NZD 45.19 million, a significant decline from the previous year’s profit of NZD 82.00 million. The company’s earnings per share also dropped to a negative 4.4 cents from 11.9 cents. Key financial metrics revealed a challenging period for Ryman Healthcare, with increased operating expenses and finance costs impacting profitability. The fair value movement of investment properties was notably lower than the previous year, contributing to the overall loss. Despite these challenges, the company continues to focus on its core operations in the aged care sector across New Zealand and Australia. Looking ahead, Ryman Healthcare remains committed to navigating the current economic environment while focusing on long-term growth and stability in the retirement village and aged care sectors.

